These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 9926943

  • 1. Functional association of TGF-beta receptor II with cyclin B.
    Liu JH, Wei S, Burnette PK, Gamero AM, Hutton M, Djeu JY.
    Oncogene; 1999 Jan 07; 18(1):269-75. PubMed ID: 9926943
    [Abstract] [Full Text] [Related]

  • 2. TGFbeta regulates the expression and activities of G2 checkpoint kinases in human myeloid leukemia cells.
    Hu X, Cui D, Moscinski LC, Zhang X, Maccachero V, Zuckerman KS.
    Cytokine; 2007 Feb 07; 37(2):155-62. PubMed ID: 17459720
    [Abstract] [Full Text] [Related]

  • 3. Either cyclin B1 or B2 is necessary and sufficient for inducing germinal vesicle breakdown during frog (Rana japonica) oocyte maturation.
    Ihara J, Yoshida N, Tanaka T, Mita K, Yamashita M.
    Mol Reprod Dev; 1998 Aug 07; 50(4):499-509. PubMed ID: 9669534
    [Abstract] [Full Text] [Related]

  • 4. Cyclin B2/cyclin-dependent kinase1 dissociation precedes CDK1 Thr-161 dephosphorylation upon M-phase promoting factor inactivation in Xenopus laevis cell-free extract.
    Chesnel F, Bazile F, Pascal A, Kubiak JZ.
    Int J Dev Biol; 2007 Aug 07; 51(4):297-305. PubMed ID: 17554681
    [Abstract] [Full Text] [Related]

  • 5. Double-stranded RNA-dependent protein kinase, PKR, down-regulates CDC2/cyclin B1 and induces apoptosis in non-transformed but not in v-mos transformed cells.
    Dagon Y, Dovrat S, Vilchik S, Hacohen D, Shlomo G, Sredni B, Salzberg S, Nir U.
    Oncogene; 2001 Dec 06; 20(56):8045-56. PubMed ID: 11781817
    [Abstract] [Full Text] [Related]

  • 6. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
    Fralix KD, Zhao S, Venkatasubbarao K, Freeman JW.
    J Cell Physiol; 2003 Jan 06; 194(1):88-99. PubMed ID: 12447993
    [Abstract] [Full Text] [Related]

  • 7. A novel dominant negative Smad2 mutation in a TGFbeta resistant human carcinoma cell line.
    Tsang KJ, Tsang D, Brown TN, Crowe DL.
    Anticancer Res; 2002 Jan 06; 22(1A):13-9. PubMed ID: 12017275
    [Abstract] [Full Text] [Related]

  • 8. Phosphorylation of the cyclin b1 cytoplasmic retention sequence by mitogen-activated protein kinase and Plx.
    Walsh S, Margolis SS, Kornbluth S.
    Mol Cancer Res; 2003 Feb 06; 1(4):280-9. PubMed ID: 12612056
    [Abstract] [Full Text] [Related]

  • 9. Geldanamycin induces G2 arrest in U87MG glioblastoma cells through downregulation of Cdc2 and cyclin B1.
    Nomura N, Nomura M, Newcomb EW, Zagzag D.
    Biochem Pharmacol; 2007 May 15; 73(10):1528-36. PubMed ID: 17324379
    [Abstract] [Full Text] [Related]

  • 10. Ligand-induced dimerization of the extracellular domain of the TGF-beta receptor type II.
    Letourneur O, Goetschy JF, Horisberger M, Grütter MG.
    Biochem Biophys Res Commun; 1996 Jul 25; 224(3):709-16. PubMed ID: 8713111
    [Abstract] [Full Text] [Related]

  • 11. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.
    Park M, Chae HD, Yun J, Jung M, Kim YS, Kim SH, Han MH, Shin DY.
    Cancer Res; 2000 Feb 01; 60(3):542-5. PubMed ID: 10676633
    [Abstract] [Full Text] [Related]

  • 12. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
    Kubo M, Ihn H, Yamane K, Tamaki K.
    Br J Dermatol; 2006 May 01; 154(5):919-25. PubMed ID: 16634896
    [Abstract] [Full Text] [Related]

  • 13. Growth factor-binding sequence in human alpha2-macroglobulin targets the receptor-binding site in transforming growth factor-beta.
    Arandjelovic S, Freed TA, Gonias SL.
    Biochemistry; 2003 May 27; 42(20):6121-7. PubMed ID: 12755614
    [Abstract] [Full Text] [Related]

  • 14. Predominant cytosolic localization of type II transforming growth factor beta receptors in human breast carcinoma cells.
    Koli KM, Arteaga CL.
    Cancer Res; 1997 Mar 01; 57(5):970-7. PubMed ID: 9041203
    [Abstract] [Full Text] [Related]

  • 15. Modulation of cell-cycle regulatory signaling network by 2-methoxyestradiol in prostate cancer cells is mediated through multiple signal transduction pathways.
    Ray G, Dhar G, Van Veldhuizen PJ, Banerjee S, Saxena NK, Sengupta K, Banerjee SK.
    Biochemistry; 2006 Mar 21; 45(11):3703-13. PubMed ID: 16533053
    [Abstract] [Full Text] [Related]

  • 16. Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells.
    Yang HK, Kang SH, Kim YS, Won K, Bang YJ, Kim SJ.
    Oncogene; 1999 Apr 01; 18(13):2213-9. PubMed ID: 10327067
    [Abstract] [Full Text] [Related]

  • 17. Interaction of transforming growth factor beta receptors with apolipoprotein J/clusterin.
    Reddy KB, Karode MC, Harmony AK, Howe PH.
    Biochemistry; 1996 Jan 09; 35(1):309-14. PubMed ID: 8555189
    [Abstract] [Full Text] [Related]

  • 18. Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers.
    Takenoshita S, Tani M, Nagashima M, Hagiwara K, Bennett WP, Yokota J, Harris CC.
    Oncogene; 1997 Mar 13; 14(10):1255-8. PubMed ID: 9121777
    [Abstract] [Full Text] [Related]

  • 19. Ethanol metabolism results in a G2/M cell-cycle arrest in recombinant Hep G2 cells.
    Clemens DL, Calisto LE, Sorrell MF, Tuma DJ.
    Hepatology; 2003 Aug 13; 38(2):385-93. PubMed ID: 12883482
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
    Joyce NC, Harris DL, Mello DM.
    Invest Ophthalmol Vis Sci; 2002 Jul 13; 43(7):2152-9. PubMed ID: 12091410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.